GeoVax Labs, Inc. has announced a significant corporate action: a 1-for-24 reverse stock split. This decision, effective November 11, 2026, is intended to consolidate shares and potentially enhance the market perception of the company's stock.

The reverse stock split means that every 24 shares of the company’s common stock will be combined into one share. This action is designed to increase the price per share, which may improve the company's appeal to investors and help meet listing requirements on stock exchanges.

Background

GeoVax Labs, Inc. operates in the pharmaceutical preparations sector, specifically focusing on developing innovative therapies and vaccines. The company is listed on the Nasdaq under the ticker symbol GOVX. The recent filing, dated November 12, 2026, includes updates on the company's corporate structure and share modifications.

What the Filing Says

The SEC filing states, "On November 10, 2026, GeoVax Labs, Inc. filed a Certificate of Amendment to our Certificate of Incorporation effecting a 1-for-24 reverse stock split." This amendment was adopted by the company’s Board of Directors and stockholders, indicating a strategic move to enhance shareholder value.

Impact

This reverse stock split may affect existing shareholders by consolidating their holdings, but it is designed to maintain their proportional ownership and voting rights in the company. The filing reassures that no fractional shares will be issued, and any fractions will be rounded up to the nearest whole share.

What's Next

The filing does not specify what happens next following the reverse stock split. However, it indicates that the rights and privileges of the holders of shares of common stock remain substantially unchanged.